Each fact below includes its exact scope, evidence status and review dates. Missing or conflicting information stays unconfirmed.
Country (Wikidata; date unspecified)
Stated by a public source
Netherlands
Wikidata Q30284525 property P17. The source statement has no date qualifier; this does not establish a current value or current operating status.
Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.
Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1
Headquarters location (Wikidata; date unspecified)
Stated by a public source
Amsterdam
Wikidata Q30284525 property P159. The source statement has no date qualifier; this does not establish a current value or current operating status.
Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.
Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1
Inception (Wikidata)
Stated by a public source
2003-01-01
Wikidata Q30284525 property P571. Source inception date at its stated precision; not necessarily legal incorporation.
Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.
Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1
MammaPrint and BluePrint
Published by the business
MammaPrint and BluePrint: Genomic tests described by Agendia for assessment of breast-cancer recurrence risk and tumour biology.
Company-described test purposes only; clinical performance, regulatory approval, insurance coverage, patient eligibility and treatment decisions require separate evidence.
Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.
Reviewed 2026-10-19 · Review due 2027-01-17 · Version 1
Official website (Wikidata; date unspecified)
Stated by a public source
http://www.agendia.com/
Wikidata Q30284525 property P856. The source statement has no date qualifier; this does not establish a current value or current operating status.
Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.
Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1
Published focus
Published by the business
Genomic testing for early-stage breast cancer and its care teams
Business-published area of work; this is not a clinical recommendation or independent assessment of diagnostic performance.
Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.
Reviewed 2026-10-19 · Review due 2027-01-17 · Version 1
Published overview
Published by the business
Agendia is a molecular diagnostics company focused on breast cancer. It offers MammaPrint and BluePrint genomic tests, which the company describes as assessing recurrence risk and tumour biology to inform early-stage breast-cancer treatment planning.
Published description of Agendia on the cited official website; observation dates are recorded with each source.
Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.